{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:45:23Z","timestamp":1792856723079,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,7]]},"DOI":"10.7759\/cureus.94077","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:02:23Z","timestamp":1759899743000},"source":"Crossref","is-referenced-by-count":1,"title":["An Elusive Diagnosis of Autosomal Dominant Alport Syndrome: Genomic Sequencing Is a Game Changer"],"prefix":"10.7759","author":[{"given":"Achilleas","family":"Betsikos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Geladari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Gazouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Sabanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw095","article-title":"Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport syndrome","volume":"32","author":"Gross O","year":"2017","unstructured":"Gross O, Kashtan CE, Rheault MN, et al.. Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport syndrome. Nephrol Dial Transplant. 2017, 32:916-24. 10.1093\/ndt\/gfw095","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport syndrome classification working group","volume":"93","author":"Kashtan CE","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G, et al.. Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport syndrome classification working group. Kidney Int. 2018, 93:1045-51. 10.1016\/j.kint.2017.12.018","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100631","article-title":"Alport syndrome: clinical spectrum and therapeutic advances","volume":"5","author":"Gregorio V","year":"2023","unstructured":"Gregorio V, Caparali EB, Shojaei A, et al.. Alport syndrome: clinical spectrum and therapeutic advances. Kidney Med. 2023, 5:100631. 10.1016\/j.xkme.2023.100631","journal-title":"Kidney Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary familial congenital haemorrhagic nephritis","volume":"1","author":"Alport AC","year":"1927","unstructured":"Alport AC. Hereditary familial congenital haemorrhagic nephritis. Br Med J. 1927, 1:504-6. 10.1136\/bmj.1.3454.504","journal-title":"Br Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024, 105:S117-314. 10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00379.x","article-title":"COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome","volume":"61","author":"Longo I","year":"2002","unstructured":"Longo I, Porcedda P, Mari F, et al.. COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int. 2002, 61:1947-56. 10.1046\/j.1523-1755.2002.00379.x","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation","volume":"59","author":"Anna A","year":"2018","unstructured":"Anna A, Monika G. Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet. 2018, 59:253-68. 10.1007\/s13353-018-0444-7","journal-title":"J Appl Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/genes11111377","article-title":"Mutations in collagen genes in the context of an isolated population","volume":"11","author":"Zupan A","year":"2020","unstructured":"Zupan A, Matja\u0161i\u010d A, Grubelnik G, et al.. Mutations in collagen genes in the context of an isolated population. Genes (Basel). 2020, 11:10.3390\/genes11111377","journal-title":"Genes (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/genes15081016","article-title":"Alport syndrome: clinical utility of early genetic diagnosis in children","volume":"15","author":"Christodoulaki V","year":"2024","unstructured":"Christodoulaki V, Kosma K, Marinakis NM, et al.. Alport syndrome: clinical utility of early genetic diagnosis in children. Genes (Basel). 2024, 15:10.3390\/genes15081016","journal-title":"Genes (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100590","article-title":"Collagen IV(\u03b1345) dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture's and Alport diseases","volume":"296","author":"Pokidysheva EN","year":"2021","unstructured":"Pokidysheva EN, Seeger H, Pedchenko V, et al.. Collagen IV(\u03b1345) dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture's and Alport diseases. J Biol Chem. 2021, 296:100590. 10.1016\/j.jbc.2021.100590","journal-title":"J Biol Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405562-an-elusive-diagnosis-of-autosomal-dominant-alport-syndrome-genomic-sequencing-is-a-game-changer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:02:24Z","timestamp":1759899744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405562-an-elusive-diagnosis-of-autosomal-dominant-alport-syndrome-genomic-sequencing-is-a-game-changer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.94077","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}